10 results
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
27 Oct 15
Current report (foreign)
12:00am
/nuclear protein aggregations in affected muscle cells Competition □ None Overview Dysphagia # 3 Dysphagia operation 39.6% Repeated operation 67% Number
424B5
ENLV
Enlivex Therapeutics Ltd
18 Mar 16
Prospectus supplement for primary offering
12:00am
and was identified within the typical cellular protein aggregates - the intra-nuclear inclusion body (INI) that are the diagnostic hallmark of the disease
6-K
EX-99.2
i6jjpitzt49bwl
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
- Prev
- 1
- Next